Cigna Group closed 23.69% below its 52-week high of $370.83, which the company reached on September 16th.

Shares of Cigna (NYSE: CI) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% ...

Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, as ...

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

Thursday, the Cigna Group (CI) shares fell 8.86 percent to $276.43 as the company faced market turmoil. The stock slid as much as ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Management projects 2025 adjusted EPS of at least $29.50, supported by biosimilar growth and strategic investments. Full-year consolidated adjusted revenue is expected to exceed $252 billion.

The Cigna Group reported today their total revenue of $247.1 billion for 2024, compared with $195.3 billion in 2023. This growth highlights the company’s strong financial results, supported by ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...